Switching H2-antagonists to OTC status has failed to reduce the physician consultation rate

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.314, 2001-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching of H2-Receptor Antagonists to Over-the-Counter Status in Finland: Implications for Consumption and Adverse Effects

By Närhi Ulla

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

No adverse effect of Rx-to-OTC switch for H2RAs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The pros and cons of Rx-to-OTC switching of drugs in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The pros and cons of Rx-to-OTC switching of drugs in the US

Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Statins poor contenders for OTC status, says expert

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite